Ownership
Private
Employees
~48
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Evolva General Information
Evolva has commercialized several nature-based ingredients produced via precision fermentation; notable products include Veri-te resveratrol and aroma components like Valencene and Nootkatone. The company was acquired by Lallemand in late 2023 to expand its global reach.
Contact Information
Drug Pipeline
Veri-te resveratrol
CommercialKey Partnerships
Now part of the broader partnership network of Lallemand Inc.; previous partnerships not detailed in current results.
Evolva Funding
No funding data available
To view Evolva's complete valuation and funding history, request access »
Gosset